Sign In
Buy CME
$237.38
-7.73 (-3.15%)
At Close: Jul 21, 2026
CME Group Stock Topped The Consensus In Q1, Is It A Buy?
07:30am, Monday, 02'nd May 2022
CME Group's stock has lost 1% YTD, while the S&P500 is down 12% over the same period. Further, at its current price of $226 per share, it is trading 7% below its fair value of $243 – Trefis' estimat
Why CME Should Be In Our Dividend Growth Portfolios
01:06am, Saturday, 30'th Apr 2022
CME Group is a great mix between growth and value as it offers a good yield and long-term (expected) outperformance. Because of its business model, the company is able to generate high free cash flow
Cboe Global (CBOE) Q1 Earnings & Revenues Beat Estimates
03:32pm, Friday, 29'th Apr 2022 Zacks Investment Research
Cboe Global (CBOE) Q1 results reflect higher net transaction and clearing fees, access and capacity fees, and market data, offset by higher expenses.
Several Reasons to Target CME Group Stock in May
12:28pm, Thursday, 28'th Apr 2022
With April coming to a close, traders have the chance to revisit their portfolios and make the necessary adjustments.
10 Biggest Price Target Changes For Thursday
11:35am, Thursday, 28'th Apr 2022 Benzinga
Needham lowered MKS Instruments, Inc. (NASDAQ: MKSI) price target from $185 to $175. MKS Instruments shares rose 3.6% to $116.01 in pre-market trading.
Piper Sandler cut the price target for PayPal
CME Group (CME) Q1 Earnings and Revenues Beat Estimates
03:46pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
CME Group (CME) Q1 results reflect higher revenues and lower expenses.
CME Group (CME) Q1 Earnings and Revenues Beat Estimates
01:03pm, Wednesday, 27'th Apr 2022
CME Group (CME) Q1 results reflect higher revenues and lower expenses.
CME Group (CME) Surpasses Q1 Earnings and Revenue Estimates
12:25pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
CME (CME) delivered earnings and revenue surprises of 5.50% and 2.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
CME Group's (CME) CEO Terry Duffy on Q1 2022 Results - Earnings Call Transcript
12:19pm, Wednesday, 27'th Apr 2022
CME Group Inc. (NASDAQ:CME ) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants John Peschier – Managing Director-Investor Relations Terry Duffy – Chairman and Chief E
CME Group (CME) Surpasses Q1 Earnings and Revenue Estimates
10:02am, Wednesday, 27'th Apr 2022
CME (CME) delivered earnings and revenue surprises of 5.50% and 2.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why CME Group (CME) Might Surprise This Earnings Season
12:42pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
CME Group (CME) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why CME (CME) is Poised to Beat Earnings Estimates Again
04:10pm, Monday, 25'th Apr 2022 Zacks Investment Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why CME (CME) is Poised to Beat Earnings Estimates Again
01:32pm, Monday, 25'th Apr 2022
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is a Beat in the Cards for CME Group (CME) in Q1 Earnings?
01:06pm, Friday, 22'nd Apr 2022 Zacks Investment Research
CME Group's (CME) first-quarter performance is likely to have been aided by higher clearing, transaction fees and other revenues, market data and information services and lower expenses.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess
11:08am, Friday, 22'nd Apr 2022 Zacks Investment Research
Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess have been highlighted in this Industry Outlook article.
